OCTALIA Technologies relies on highly experimented scientist always on the go to discover
new formulations and drug delivery concepts, which enables you to extend your IP portfolio.
This small, reactive and efficient team will help you to optimize your developments and save precious time.
Michèle BOIX
CEO, Cofounder, Head of Formulation
+33 (0) 4 97 21 33 34
Marina DO
Managing Director, Cofounder, Head of Analysis
+33 (0) 4 97 21 33 35
Chloé JEAN-PIERRE
Scientist Formulation and Analysis
+33 (0) 4 97 21 33 32
Alain PITON / ALPQS
Quality Manager
+33 (0) 4 97 21 33 31
Strongly committed to customer satisfaction, OCTALIA has built solid relationships with local and national partners (private and public) to efficiently support and complement your project development needs form the early stage to the non-clinical phases and industrial transfers: